Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
The World Anti-Doping Agency (WADA) has declared it a prohibited substance as of 2022
The US Food and Drug Administration approved Bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder (HSDD) in 2019
Rights and permissions Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
Reference: Gwyer D, Wragg NM, Wilson SL (2019)
US$ 22.54
US$ 29.94
US$ 20.58
US$ 26.67
US$ 26.36
